drugset / Trial / NCT01800097

Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent

NCT01800097

Phase 3 Terminated 41 enrolled Herlev Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is an investigator initiated placebo controlled double blinded trial. The hypothesis is that treatment with modafinil positively will affect behavioural and cognitive rehabilitation after stroke, causing the treatment group to experience decreased fatigue, increased endurance, improved skills of sustaining attention and faster reaction times. The cognitive rehabilitation will show in increased muscle mass, decreased osteoporosis and better physical performances due to a higher level of physical activity.

Timeline

Start
2012-10
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Modafinil Small molecule 200 mg Oral
Comparator Modafinil Small molecule 400 mg Oral

Indications